Results 21 to 30 of about 20,868 (291)

The Bibliometric Aspects of Case Report/Series in Science Citation Index Otorhinolaryngology Journals

open access: yesTurkish Archives of Otorhinolaryngology, 2021
Objective:The rate of case report/series (CR/S) acceptance by the high impact journals is steadily declining mainly due to low citations.
Nesibe Gül Yüksel Aslıer   +1 more
doaj   +1 more source

Comparison of intellectual structure of knowledge in international journal of preventive medicine with MeSH: A co-word analysis

open access: yesInternational Journal of Preventive Medicine, 2019
Background: The aim of the current study is to determine the Comparison of intellectual structure of International Journal of Preventive Medicine (IJPM) with Medical Subject Headings (MeSH) based on author keywords and index terms of Scopus database and ...
Elaheh Mazaheri   +2 more
doaj   +1 more source

Current status of Indonesian journals in the field of Islamic economics and finance [PDF]

open access: yesScience Editing, 2020
This study aimed to explore the status of Indonesian journals in the discipline of Islamic economics and finance. In the last two decades, the emergence of Islamic economic journals was striking.
Luqman Hakim Handoko
doaj   +1 more source

Bibliographic Control of Serial Publications [PDF]

open access: yes, 1969
An important problem with serials is bibliographic control. What good does it do for libraries to select, acquire, record, catalog, and bind large holdings of serial publications if the contents of those serials remain a mystery to all except the few ...
Woods, Bill M.
core  

Carcinomas and Carcinoid Tumors of the Lungs and Bronchi in Children and Adolescents: The EXPeRT Recommendations

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Primary lung carcinomas and bronchial carcinoid tumors (BC) are very rare malignancies in childhood. While typical BC and mucoepidermoid carcinomas are mostly low‐grade, localized tumors with a more favorable prognosis than in adults, necessitating avoidance of overtreatment, adenocarcinomas of the lung are often diagnosed at advanced disease ...
Michael Abele   +19 more
wiley   +1 more source

Special Libraries, December 1961 [PDF]

open access: yes, 1960
Volume 52, Issue 10https://scholarworks.sjsu.edu/sla_sl_1961/1009/thumbnail ...
Special Libraries Association
core   +3 more sources

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

Gemcitabine, Docetaxel, Melphalan, Carboplatin as Part of Sequential Cycles of High‐Dose Chemotherapy With Autologous Hematopoietic Stem‐Cell Rescue for Multiply Relapsed/Refractory Pediatric Germ Cell Tumors

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Although most malignant germ cell tumors (GCTs) are highly curable with cisplatin‐based therapy, options for patients with multiply relapsed/refractory disease remain limited. For this population, we report the first pediatric use of gemcitabine, docetaxel, melphalan, and carboplatin (GemDMC) as part of sequential cycles of high‐dose ...
Maria Frost   +10 more
wiley   +1 more source

Abstracts and Abstracting in Knowledge Discovery [PDF]

open access: yes, 1999
published or submitted for ...
Lancaster, F.W., Pinto, Maria
core  

CPX‐351 in High‐Risk Relapsed Pediatric Acute Leukemia: Real‐World Phase 1 Data Establishing the FDA‐Approved Dose

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background/Objectives Outcomes for pediatric relapsed/refractory (R/R) acute myeloid leukemia (AML) remain dismal. CPX‐351, a liposomal formulation of cytarabine and daunorubicin, may have less off‐target toxicities than traditional chemotherapies and has shown improved outcomes for adults with newly diagnosed therapy‐related AML.
Jonathan D. Bender   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy